The allotment for the ₹69.04 crore Pramodini Medicare IPO is anticipated to be finalised today, August 17, 2026. Investors can check their status through official platforms, such as the NSE website and the portal of the IPO registrar, Purva Sharegistry Private Limited.

Following the completion of the allotment process, the shares are tentatively scheduled to be listed on the NSE SME platform on August 19, 2026.

Procedure to Check Pramodini Medicare IPO Allotment Status Online on NSE

Visit the NSE’s IPO allotment verification status page here.
Select “Equity & SME IPO Bid Details”.
In Select, choose “PRAMODINI”.
Enter your PAN No. and Application No.
Click “Submit”.

Procedure to Check Pramodini Medicare IPO Allotment Status on Purva Sharegistry Private Limited (Registrar to the issue)

Visit the Purva Sharegistry’s IPO allotment status page here.
In Select Company, select “Pramodini Medicare”.
Enter any of the following details.

App. No.
PAN Number Demat Acct

Click “Search”.

Pramodini Medicare IPO - Issue Details

Issue Type: Book Built Issue (Fresh Issue + OFS)
Total Issue Size: Up to ₹69.04 crore
Fresh Issue: Up to ₹63.14 crore
Offer for Sale (OFS): Up to ₹5.90 crore
Face Value: ₹10 per equity share
Price Band: ₹110 to ₹118 per share
Lot Size: 1,200 shares
Minimum Investment Amount (Retail Investor): ₹2,83,200 (2,400 shares based on upper price)
Listing: NSE SME
Book Running Lead Managers: Smart Horizon Capital Advisors Private Limited
Registrar: Purva Sharegistry (India) Private Limited

Explore other Upcoming IPOs on BSE and NSE.

Pramodini Medicare IPO Overall Subscription Status

[August 14, 2026, 7:00 PM]

Category	Subscription (x)
Qualified Institutional Buyers (QIBs)	3.66x
Non-Institutional Investors (NIIs)	4.96x
Retail Individual Investors (RIIs)	3.49x
Total	3.87x

Utilisation of IPO Proceeds

The company intends to utilise the net proceeds from the fresh issue towards:

Funding of capital expenditure for purchase of medical equipments towards existing and proposed diagnostic centres
General corporate purposes and unidentified inorganic acquisitions.

About Pramodini Medicare Limited

Incorporated in 2000, Pramodini Medicare Limited provides technology-enabled diagnostic services across radiology, clinical laboratory testing and nuclear medicine. Its customers include government and private hospitals, medical colleges, PSUs and diagnostic centres across Tier I, II and III cities. Its services cover MRI, CT scans, X-rays, ultrasound, mammography, laboratory testing, PET-CT, SPECT and nuclear therapy.

The company operates through public-private and private-private partnerships, collaborations with PSUs, and standalone diagnostic centres. As of August 4, 2026, it operated 16 diagnostic centres across seven states, along with a 24×7 teleradiology unit and a processing laboratory in Vijayawada. As of March 31, 2026, the company had 161 permanent employees.

Key Financial Highlights

Particulars	FY26 (in ₹ crore)	FY25 (in ₹ crore)	FY24 (in ₹ crore)
Revenue from operations	62.29	38.24	35.23
EBITDA	30.90	20.97	15.53
Profit After Tax (PAT)	17.38	11.14	7.14